FOXC1 and breast cancer: The observed FOXC1 downregulation in APL was however at least in part due to aberrant DNA hypermethylation, identified in CpGs localized next to the TSS (from + 354 to + 368), whose regulatory role has been previously shown by Klajic et al. in breast cancer cells [21].